The authoritative source of FDA-approved information on prescription drugs.

Physicians have turned to PDRŽ for the latest word on prescription drugs for over 60 years! Today, PDRŽ is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital, and pharmacy in the United States. In fact, nine out of 10 doctors consider PDRŽ their most important drug information reference source.

The 61st edition contains more than 3,000 pages-our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now.

Among the new drugs featured in this edition are:

• Amitiza (lubiprostone)
• Daytrana (methylphenidate transdermal system)
• Nexavar (sorafenib)
• Proquad (measles, mumps, rubella and varicella vaccine)
• Ranexa (ranolazine extended-release tablets)
• Sutent (sunitinib malate)
• Vivaglobin (immune globulin subcutaneous [human])

You'll find the most complete data on more than 4,000 drugs by both brand and generic name (in the same convenient index), manufacturer and product category. The 2007 PDRŽ provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross-referenced to the drug.